However, current evidence suggests that the prognosis of KIT exon 9 mutated intestinal GIST is poor, and 800 mg imatinib is recommended for initial administration every day.[21] It is widely acknowledged that imatinib is the gold standard for patients with advanced or metastatic GIST disease. Here, KIT is linked to gastrointestinal stromal tumor.